Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations-Reference-Cited by-同舟云学术

Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations

Published:2006-03-02 Issue:5 Volume:20 Page:807-813
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chng W J,Santana-Dávila R,Van Wier S A,Ahmann G J,Jalal S M,Bergsagel P L,Chesi M,Trendle M C,Jacobus S,Blood E,Oken M M,Henderson K,Kyle R A,Gertz M A,Lacy M Q,Dispenzieri A,Greipp P R,Fonseca R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404172.pdf

Reference42 articles.

1. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM . Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 1996; 93: 13931–13936.

2. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM . Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 1996; 88: 674–681.

3. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997; 16: 260–264.

4. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL . The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood 1998; 92: 3025–3034.

5. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood 1998; 91: 4457–4463.

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway;Journal of Cancer Research and Clinical Oncology;2024-05-07

2. A diagnostic approach to detect cytogenetic heterogeneity and its prognostic significance in multiple myeloma;Journal of Taibah University Medical Sciences;2023-10

3. Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology;Virchows Archiv;2023-08-10

4. Molecular genetic aberrations in the pathogenesis of multiple myeloma;Asian Biomedicine;2023-08-01

5. High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions;Blood Cancer Journal;2022-05-30